Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Heads Of HHS, FDA Outline Biden's Budget Proposals To US Congress

Executive Summary

US President Joe Biden’s proposed budget for fiscal 2022 allocates $133.7bn for HHS, a 23% increase for the department from fiscal 2021; the administration is also asking for $6.5bn for the FDA, an 8% increase from the agency’s current budget.

You may also be interested in...



Congressional Action Needed To Protect Device Supply Chain, FDA’s Woodcock Says

The US FDA needs enhanced authorities as well as increased funding to track and prevent device shortages, acting commissioner Janet Woodcock argues.

FDA’s Woodcock Pitches Large IT Modernization Plan

In a new blogpost the US FDA acting commissioner says millions of extra dollars in President Joe Biden’s recently proposed budget would help integrate the agency’s IT systems and improve efficiencies.

Biden’s Budget Would Give $6.5Bn To FDA, Including $677M To Device Center

The funding plan from the US president, which is up 8% from fiscal 2021, prioritizes infrastructure, public health, and safety programs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT144078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel